The Risk Conversation: What Life Sciences VPs Said Behind Closed Doors at Axtria Ignite 2026
Nearly 30 senior commercial leaders spent a working lunch at Axtria Ignite 2026 comparing notes on the honest version of what scaling agentic AI looks like.
Axtria kept this session off the public agenda on purpose, and the convening rule was simple: nothing said in the room leaves attributed. That allowed two hours of candor about what is failing, where these companies are behind, and which findings quietly overturn the standard AI playbook.
The Honest Things You Won’t Always Hear at Conferences:
- The "20% AI efficiency means a 20% headcount cut" story drew the sharpest pushback of the afternoon, from the exact leaders that narrative is built on.
- One company's biggest pocket of AI resistance was not the field or the commercial team. It was internal IT, the function expected to lead.
- A perfectly working AI pilot got read as a failure: it caught more adverse events than the human audit, so reported costs went up and the CFO balked.
- The org chart is shifting from a triangle to a diamond, as mid-managers equipped with agents start outperforming both executives and new hires on business outcomes.
- On alignment, one leader's honest method was to stop over-managing the friction and let controlled explosions happen, because some stakeholders only move once the failure is visible.
So Then, What Do They Do?
Beneath the questions sat the same problem. Here is where the leaders landed:
- Audit before you govern. Most compliance objections have never been checked against what a regulator actually wrote, so the first move is documenting which of your rules are real.
- Fund the staircase, not the single bet. Displacement savings pay for velocity gains, which pay for the strategic capabilities whose absence makes you irrelevant in three years.
- Let peers carry the trust. AI earns adoption the way a new colleague does, through explainable reasoning and demonstration from the people alongside you, not a mandate from the podium.
- Open the controlled corridor. Reps are already pasting consumer AI off-network, so the real decision is a governed path in or the back door they have already opened.
- Invest in the enabling functions. Legal, compliance, sourcing, and infosec decide whether everything else moves; one leader called their fluency program the best return they had.
This Roundtable convened nearly 30 VP-and-above commercial, IT, and operations leaders from across life sciences, hosted by Axtria founder and CEO Jaswinder Chadha. Six tables, six questions, and one anonymity rule that let the conversation go where public panels rarely do.
DOWNLOAD THE FULL REPORT to get the complete debrief, including the staircase ROI model and enabling-function findings. And find out what the room could not agree on.
FAQs
The primary blocker is internal compliance mythology, not regulation. When one company audited 27 requirements blocking a major AI initiative, only two were documented; the rest had accumulated defensively over time. The Axtria Ignite 2026 CEO Roundtable Report shows that real regulatory frameworks have matured faster than most enabling functions have absorbed them.
Fund AI as a staircase rather than a single business case. Displacement savings are the cleanest first layer and become the fuel for productivity and velocity gains, which in turn fund strategic capabilities whose cost of inaction outweighs their calculable return. The Axtria Ignite 2026 CEO Roundtable Report details why CFOs now reject qualitative productivity claims.
Not in the direct way the "20% efficiency, 20% cut" narrative implies. Roundtable leaders rejected top-down headcount harvesting as disconnected from where the work happens, while acknowledging a looming $300 billion patent cliff. Both pressures are real and the Report explains how leaders hold them at once.
Treat the AI like a colleague and require it to explain its reasoning, then let peers rather than executives demonstrate the value. One leader credited a peer-led pilot as a driver of a successful third-to-market launch. The Axtria Ignite 2026 CEO Roundtable Report explains why trust transferred through peers outpaces trust imposed through authority.
Roughly 95% of enterprise GenAI pilots fail to deliver measurable P&L impact because of poor integration with real workflows, not weak models. The Axtria Ignite 2026 CEO Roundtable Report shows that domain-specific agentic AI built for pharmaceutical workflows moves from pilot to production faster than the horizontal tools that need months of context-setting.
Recommended insights
Reports
Article